Tagged with R

Taiwan Dr Hardy Chan shares the story of how he came out of retirement to lead Allianz Pharmascience; an up-and-coming biotech which aims to meet the unmet medical needs of rare disease patients, particularly in Asia. Dr Chan delves deep into the innovative science behind the company’s pipeline and shares the…

Opinion Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies for attracting and retaining talent in these rapidly emerging fields.   In a young industry experiencing rapid growth, talent demand far outweighs supply Cell & Gene Therapy; “It’s no longer something people read about…

Opinion Frost & Sullivan’s Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine, is already having on the global therapeutic landscape, and how the Asia-Pacific region is positioning itself at the forefront of this trend.   Providing the right treatment/ right drug at the…

Taiwan Grace Yang, general manager of TSH Biopharm, discusses how the company is uniquely positioned to deliver end-to-end healthcare solutions to the APAC region in the areas of cardiovascular, gastrointestinal, autoimmune, central nervous system, and why TSH step in to cancer diagnosis business area. Yang goes on to explain how TSH…

Sweden Eric Wahlberg, CEO of Uppsala University Hospital, Sweden´s oldest university hospital, explains his strategic vision of hospital management and how Uppsala is utilising e-health, precision medicine, clinical trials, small biotech companies and the use of IT systems in hospitals.   I understand how doctors and nurses think, and what their…

China HE Ming, founder and CEO of Sino-American (Suzhou) Pharmaceutical Services (SAPS), shares his commitment to bringing international quality standards to the Chinese pharma industry, the comprehensive portfolio of quality management, verification and compliance services SAPS offers to the pharma, biotech and medical device industries in China and the US, as…

Sweden Jakob Tellgren recently returned from MSD’s US headquarters to his home country of Sweden to take the helm of the Nordic and Baltic countries. He shares the importance of Sweden and the Nordics for the group and his plans to continue driving the outstanding performance of the affiliate while bringing…

Taiwan Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s adoption of the emerging field.   In order to succeed in translating precision medicine to clinical practice, quality laboratories under strong regulations must be created   What motivates you…

Sweden Karolinska Institutet (KI) is a centre of excellence for medical research and education in Sweden and the world. Ole Petter Ottersen has been the president of KI since 2017. Prior to this, he was the president of the University of Oslo and director of the Centre for Molecular Biology and…

China Dr Shuqian Jing, founder, Chairman and CEO of Gmax Biopharm, an innovative biotech company headquartered in Hangzhou, shares how his experiences at global biopharma companies like BMS and Amgen inspired him to create his own biotech company; Gmax’s focus on G protein-coupled receptor (GPCR) therapeutic antibodies; the exciting pipeline the…

Puerto Rico Dr Federico Goodsaid, CEO of Puerto Rico’s first biopharmaceutical start-up MBQ Pharma, has previously worked at Vertex Pharmaceuticals and TOMA Biosciences and is considered an expert in regulatory affairs. Here, he highlights the encouraging results MBQ Pharma has achieved in preclinical efficacy and safety trials and acknowledges the backing the…

Sweden Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases. Mattias Bankel, Head of Nordics and Baltics, shares his journey of establishing and developing Amicus’s presence in Sweden and other Nordic countries, furthermore his commitment to ensure that…